Загрузка...
Breathing new life into an old target: pulmonary disease drugs for Parkinson’s disease therapy
Increases in α-synuclein protein expression are suspected to increase the risk of the development of Parkinson’s disease (PD). A recent study has demonstrated that β2-adrenergic receptor (β2AR) agonists decrease histone acetylation in the α-synuclein gene and suppress transcription. Coupled with the...
Сохранить в:
| Опубликовано в: : | Genome Med |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5649055/ https://ncbi.nlm.nih.gov/pubmed/29052536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-017-0483-4 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|